Lucid Diagnostics
LUCD
89 hedge funds and large institutions have $35.1M invested in Lucid Diagnostics in 2025 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 31 increasing their positions, 15 reducing their positions, and 14 closing their positions.
107% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 15
29% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 14
3% more funds holding
Funds holding: 86 → 89 (+3)
1% less capital invested
Capital invested by funds: $35.5M → $35.1M (-$403K)
2.25% less ownership
Funds ownership: 25.63% → 23.37% (-2.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$1.07M |
| 2 |
BlackRock
New York
|
+$719K |
| 3 |
Renaissance Technologies
New York
|
+$596K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$497K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$394K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
-$3.02M |
| 2 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
-$2.99M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.4M |
| 4 |
LM
Luminus Management
Houston,
Texas
|
-$606K |
| 5 |
Goldman Sachs
New York
|
-$303K |
LUCD Hedge Fund Activity: Q4 2025 in Review
89 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Lucid Diagnostics (LUCD) for Q4 2025, worth a combined $35.1M — down 1.1% from $35.5M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new LUCD positions and 14 closed out — a net gain of 4 holders — while 31 added to existing stakes and 15 trimmed.
The largest buyer was Aberdeen Group, adding an estimated $1.07M. The largest seller was AWM Investment Company, exiting entirely with an estimated $3.02M sold.
- 89 institutional investors held Lucid Diagnostics (LUCD) as of Q4 2025, up from 86 in Q3 2025.
- Funds reported $35.1M of Lucid Diagnostics stock for Q4 2025, down 1.1% quarter-over-quarter.
- 18 funds opened new Lucid Diagnostics positions in Q4 2025 and 14 closed out, a net change of +4 holders.
- The largest Lucid Diagnostics buyer in Q4 2025 was Aberdeen Group, an estimated $1.07M added.
- The largest Lucid Diagnostics seller in Q4 2025 was AWM Investment Company, an estimated $3.02M sold.
Based on aggregated 13F filings for Q4 2025.